DataPacts

Gengo Shigen Kyokai (GSK): Data Buyer Profile, Program Terms, Payouts and Reputation

Checked

At a glance

Gengo-Shigen-Kyokai (GSK), literally the Language Resources Association, is a Japanese non-profit founded in June 2003 that distributes speech data, lexicons and text corpora to members and non-members for per-resource fees, as checked on 2026-11-09. GSK states JPY 33,000 per resource for non-members, and its distribution service page states no provider compensation.

Independent reference. Every buyer is covered on the same terms, every figure carries its source and check date, and no buyer pays to be listed or placed higher.

Request an independent introduction

Tell us what data your company holds. We reply with the buyers that fit and what their terms leave out. Your details reach a buyer only after you agree to a named introduction.

IndependentYour details stay with us until you agreeNot selling is a valid outcome

GSK is not an AI lab and not a developer that trains models: it distributes resources that providers supply and charges the people who use them. Every figure is GSK's own statement with its check date, by the same method as every profile in this independent reference on AI training data licensing.

Each number carries its source and check date, and how DataPacts sources and dates every figure is set out in the methodology.

What Gengo Shigen Kyokai Takes In and Distributes

Language resources reach Gengo-Shigen-Kyokai from their providers and leave it under use conditions to members and non-members, so GSK sits between those who build Japanese and other language data and the organizations that use it.

  • In: language resources from providers, with terms not stated on the service page.
  • Out: per-resource distribution to non-members for a fee.
  • Out: distribution to members, with a fee for repeat use of the free member service.

The resource types GSK lists are speech data, lexicons and text corpora, checked on 2026-11-09. They are finished resources, not raw recordings or company records.

A holder of text weighs this route against a sale to a developer: a distributor hands a finished resource to many users, while text corpora for AI training licensed to a developer directly follow a bilateral deal with its own terms.

Gengo Shigen Kyokai Identity: A Japanese Non-Profit Founded in 2003

Gengo-Shigen-Kyokai is a Japanese non-profit established in June 2003, and its pages show no public registry number.

Attribute Value Source
Name Gengo-Shigen-Kyokai (GSK) gsk.or.jp/en
Meaning of the name Language Resources Association (GSK's own gloss) gsk.or.jp/en
Legal form Non-profit gsk.or.jp/en
Established June 2003 gsk.or.jp/en
Country Japan gsk.or.jp/en
Registry number None published on the pages checked gsk.or.jp/en
Website gsk.or.jp/en gsk.or.jp/en
Activity Distribution of language resources: speech data, lexicons, text corpora gsk.or.jp/en/service

Table as of 2026-11-09: the identity attributes of Gengo-Shigen-Kyokai and the GSK page each comes from.

GSK describes itself as a non-profit. A contracting party asks for the registration details in writing, because the pages checked on 2026-11-09 give none.

Whether a corpus needs a license at all depends on national law, and the rules for licensing data for AI training in Japan are covered on their own page.

Gengo Shigen Kyokai Program Terms and User Fees in Yen, Dated

GSK states its distribution fees in yen on its service page, all paid by the person or organization that uses the resource, as checked on 2026-11-09.

Term What the record shows Who pays Checked Source
Non-member fee JPY 33,000 per resource, charged per incident, taxes included User pays GSK 2026-11-09 gsk.or.jp/en/service
Member repeat use JPY 5,500 per incident for using the free member resource service more than once in a fiscal year, excluding shipping, taxes included User pays GSK 2026-11-09 gsk.or.jp/en/service
Domestic shipping JPY 3,300 User pays GSK 2026-11-09 gsk.or.jp/en/service
Taxes Included in the figures above n/a 2026-11-09 gsk.or.jp/en/service
Eligibility Members and non-members n/a 2026-11-09 gsk.or.jp/en/service
Process Forms per resource, invoice, bank transfer, delivery after payment is verified n/a 2026-11-09 gsk.or.jp/en/service
Use conditions No selling, lending or distributing to third parties; credit resources and providers n/a 2026-11-09 gsk.or.jp/en/service
Annual membership dues Not recorded n/a 2026-11-09 n/a
Provider compensation Not stated n/a 2026-11-09 gsk.or.jp/en/service
Referral fee None recorded n/a 2026-11-09 gsk.or.jp/en/service

Table as of 2026-11-09: GSK's distribution terms, who pays each amount, and what the record holds on the provider side.

Every fee runs from the resource user to GSK and not from GSK to anyone, and fees are charged per incident. Figures from different distributors use different units, so they sit beside other program terms compared without conversion or averaging.

The route is paperwork first: the user submits forms for each resource, receives an invoice, pays by bank transfer, and GSK delivers the resource after it verifies the payment.

The provider-side rows read "not stated" and "none recorded" because the service page states no provider compensation and no referral fee. Annual membership dues are not in the record checked, so none are given here.

Conditions a GSK Resource User Accepts

A GSK user may not sell, lend or distribute a resource to third parties and must credit the resource and its provider, per GSK's distribution service page checked on 2026-11-09.

Both conditions are GSK's own statements, checked on 2026-11-09, and they apply to the user, not to the provider. The first limits onward distribution, so a resource stays with the organization that obtained it. The second makes the provider visible wherever the resource is used.

Two points are not recorded in the sources checked: whether a resource may be used to train a commercial model, and whether resources carry different license grades.

The page states neither, and none is inferred here in either direction. A company that plans commercial use therefore asks GSK in writing what the resource it wants may be used for before it pays.

A no-onward-distribution clause matters to anyone comparing terms, because it fixes who may hold a copy. It sits among the clauses of an AI data licensing agreement, where it is read together with scope, term and exclusivity.

How a Language-Data Provider Offers a Resource to GSK

GSK distributes speech data, lexicons and text corpora that providers supply, and its distribution service page, checked on 2026-11-09, states no provider compensation.

  • Resource types handled: speech data, lexicons and text corpora.
  • Provider compensation: not stated on the service page.
  • Rights GSK takes: not recorded in the sources checked.
  • How to offer a resource: not recorded in the sources checked.

For a provider, "not stated" means the terms cannot be compared before contact. A provider asks GSK for the distribution contract and the payment terms in writing before agreeing, and treats the answer as the only authority on both.

The same applies to the rights GSK takes, such as whether it may distribute a resource to non-members, and to how long a resource stays in distribution.

Research groups that hold grant-funded or student-built corpora face the same question. How universities and research groups licensing data to AI companies proceed directly is covered on its own page.

The fees in the table above are payments to GSK by users and are not income of a provider.

Gengo Shigen Kyokai Reputation and the GSK Plc Name Clash, as of 2026-11-09

No complaint or incident involving Gengo-Shigen-Kyokai from a primary or named-person source appears in the record checked on 2026-11-09.

The acronym is shared, and the shared letters can send a reader to the wrong record. GSK plc, the company that licensed 23andMe's genetic database in a deal disclosed in a 23andMe filing with the SEC dated 2023-10-30, is a different company, and no relation to Gengo-Shigen-Kyokai is recorded.

Documented incidents across buyers and intermediaries are logged in the dated log of data buyer incidents, which holds no GSK entry for the non-profit.

Benefits, Risks, Downsides and Alternatives for a Data Holder Considering GSK

For a data holder, Gengo-Shigen-Kyokai offers a non-profit distribution route for language resources with published user fees but no stated provider compensation, so the practical alternatives are distributors and platforms that state provider terms, and the option of not licensing at all.

Benefits (as the record supports them)

  • A published, dated fee schedule in yen.
  • Users must credit resources and their providers.
  • A non-profit distributor focused on language resources.

Risks

  • Provider compensation and the rights GSK takes are not stated, so a provider cannot compare them before contact.
  • The record holds no statement on commercial model training by users.

Downsides

  • No payout or referral fee is recorded.
  • The route suits finished language resources, not company records in general.

Alternatives (alphabetical, each a party's claim checked 2026-11-09)

  • Defined.ai supplier program: no exclusivity and no minimums (section 3.5).
  • ELRA: the provider grants a distribution license, with compensation by contract.
  • Linguistic Data Consortium: a submissions portal for providers, with fees paid by corpus users.
  • Mozilla Data Collective: uploaders "keep 100% of revenue".
  • Not licensing at all, which keeps the data and every later option open.

A provider weighing these options compares what each party states about compensation, exclusivity and rights, because GSK states none of the three on its service page. These are claims by each party, not payments made. The full set of alternatives to selling data includes keeping the data.

Gengo Shigen Kyokai Among Corpus Distributors and Vendors

Gengo-Shigen-Kyokai is one of three language-resource distributors on the vendor side of the reference, next to the Linguistic Data Consortium and ELRA, and the only one based in Japan.

It is profiled with the other dataset vendors and data labs, and the hub on who buys AI training data places it beside every other buyer. When a distributor states no provider terms, choosing a buyer for your data covers the next step.

More About Gengo Shigen Kyokai

Frequently Asked Questions About Gengo Shigen Kyokai

Does Gengo Shigen Kyokai pay data providers?

GSK's distribution service page, checked 2026-11-09, states no provider compensation. Its published fees are paid by the people and organizations that use its resources.

How much does a GSK language resource cost?

GSK states JPY 33,000 per resource for non-members and JPY 5,500 per incident for members' repeat use of the free service in a fiscal year. Domestic shipping is JPY 3,300, taxes included (checked 2026-11-09).

Is Gengo Shigen Kyokai a company or a non-profit?

A non-profit: GSK describes itself as a Japanese non-profit distributing language resources, established in June 2003. No public registry number was found on its pages.

No relation is recorded. GSK plc, the licensee of 23andMe's genetic database, is a different company, and this page covers only the Japanese language-resource non-profit.

How does a provider offer a resource to GSK?

The record checked on 2026-11-09 does not describe GSK's provider contract or payment terms. A provider asks GSK for both in writing before offering a resource.